The deal commits pharmaceutical company Merck to keeping 300,000 vaccines ready for emergency use or further clinical trials.
Mpango huo unaitaka kampuni ya dawa ya Merck kuweka chanjo 300,000 tayari kwa matumizi ya dharura au majaribio zaidi ya kimatibabu.